We have invited UBS head of China Autos Research Paul Gong to discuss the rise of EVs in China and how this trend has ...

President-elect Trump talked tough on tariffs on his way to securing a resounding win for Republicans in November, and now ...

Self-driving features will see mass-market adoption in Chinese cars this year, thanks to fierce competition among Chinese ...

UBS expects the S&P 500 to reach 6,600 by the end of this year. In comparison, Citi, Morgan Stanley, Goldman Sachs and ...

The Swiss National Bank will likely report a record full-year profit of around 80 billion Swiss francs ($87.79 billion) for ...

ASX dips as retail data cools rate cut hopes, Star tanks on cash burn, and Bitcoin stumbles as China faces deflation.

Microsoft has reconfirmed its $128bn AI-fuelled data centre development pipeline remains on track – a positive sign for ...

Fintel reports that on January 8, 2025, UBS upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Sell to Buy. Analyst ...

Shell ( NYSE: SHEL) -2.5% in Wednesday's trading following its disappointing Q4 update, but UBS nevertheless upgrades shares ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

We recently compiled a list of the 9 Stocks Poised for Gains as AI Reaches New Heights in 2025. In this article, we are going ...

Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...